Wednesday, April 23, 2025 8:31:07 PM
BHC 5.17
20 DMA 5.34
50 DMA 6.35
200 DMA 7.16
BHC range today was 5.14-5.33 so it got rejected at the 20 DMA. With all the new lately with debt refi, Norwich losing against FDA and Ichan disclosing 34% stake we should BLAST past all the DMA's and get a golden cross a few months down the road. However this is BHC and nothing seems to work out the way you'd think it would with this stock. Next week we've got earnings so lets see how things are going.
20 DMA 5.34
50 DMA 6.35
200 DMA 7.16
BHC range today was 5.14-5.33 so it got rejected at the 20 DMA. With all the new lately with debt refi, Norwich losing against FDA and Ichan disclosing 34% stake we should BLAST past all the DMA's and get a golden cross a few months down the road. However this is BHC and nothing seems to work out the way you'd think it would with this stock. Next week we've got earnings so lets see how things are going.
Recent BHC News
- Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China • PR Newswire (US) • 05/28/2026 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:05:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:02:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 11:00:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:57:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:30:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:25:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:19:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:14:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/26/2026 10:10:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2026 09:41:33 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/20/2026 09:16:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/19/2026 08:18:10 PM
- Bausch Health Announces 2026 Annual Meeting of Shareholder Results • PR Newswire (US) • 05/19/2026 08:15:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/19/2026 01:42:39 PM
- Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference • PR Newswire (Canada) • 05/13/2026 11:00:00 AM
- Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference • PR Newswire (US) • 05/13/2026 11:00:00 AM
- Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference • PR Newswire (Canada) • 05/12/2026 08:15:00 PM
- Bausch Health to Participate in Barclays 30th Annual Leveraged Finance Conference • PR Newswire (US) • 05/12/2026 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 08:10:14 PM
- BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS • PR Newswire (Canada) • 04/29/2026 08:05:00 PM
- BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS • PR Newswire (US) • 04/29/2026 08:05:00 PM
- Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online Ordering • PR Newswire (US) • 04/14/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/08/2026 08:07:14 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/08/2026 08:06:22 PM
